J&J Files 8-K: Director Changes, Officer Comp, Shareholder Votes
Ticker: JNJ · Form: 8-K · Filed: Apr 30, 2025 · CIK: 200406
Sentiment: neutral
Topics: corporate-governance, officer-compensation, director-changes
Related Tickers: JNJ
TL;DR
JNJ filed an 8-K detailing director changes, officer compensation, and shareholder votes.
AI Summary
Johnson & Johnson filed an 8-K on April 30, 2025, reporting on the departure of directors, election of new directors, and compensatory arrangements for officers. The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits. Specific details regarding the compensatory arrangements or the matters voted upon are not elaborated in this summary.
Why It Matters
This filing provides transparency into Johnson & Johnson's corporate governance, including changes in leadership and executive compensation, which can impact investor confidence and company strategy.
Risk Assessment
Risk Level: low — The filing is routine and reports on corporate governance matters rather than significant financial events or operational changes.
Key Players & Entities
- JOHNSON & JOHNSON (company) — Filer
- 0000200406-25-000141 (filing_id) — Accession Number
- 20250430 (date) — Filing Date
- 20250424 (date) — Period of Report
FAQ
What specific items were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific proposals are not detailed in the provided text.
Who are the departing directors and the newly elected directors?
The filing states there was a departure of directors and an election of directors, but the names of these individuals are not specified in the provided text.
What are the details of the compensatory arrangements for certain officers?
The filing mentions compensatory arrangements for certain officers, but the specifics of these arrangements are not included in the provided text.
What financial statements and exhibits are included with this filing?
The filing notes that financial statements and exhibits are included, but their content is not described in the provided text.
What is the primary business of Johnson & Johnson?
Johnson & Johnson is primarily involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code [2834].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 30, 2025 regarding JOHNSON & JOHNSON (JNJ).